Ocular Proteomics LLC Profile last edited on: 11/15/17
CAGE: 5RTA5
UEI:
Business Identifier: Ocular diagnostics based on measuring biochemical signals 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
901 Dulaney Valley Road Suite 200
Towson, MD 21204
Towson, MD 21204
| (410) 244-5528 |
| jhines@ocularproteomics.com |
| www.ocularproteomics.com |
Location: Single
Congr. District: 03
County: Baltimore
Congr. District: 03
County: Baltimore
Public Profile
Ocular Proteomics is a research and development company focused on discovery, development and commercialization of biomarkers as a method of improving our understanding of ocular diseases on a molecular level. The companyâs primary research tool centers on Reverse Phase Protein Microarrays (RPMAs) to analyze longitudinal samples of vitreous humor from patients in key disease demographics, which includes Age-related Macular Degeneration (AMD) and Diabetic Retinopathy (DR). The companyâs proprietary protein panel measures activated receptor molecules and other markers in the human vitreou
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
1-4Awards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2017 | 1 | NIH | $219,009 | |
| Project Title: Development and Commercialization of Predictive Biomarker Panel and In-Office Kit for the Management of Diabetic Macular Edema | ||||
| 2014 | 2 | NIH | $1,383,746 | |
| Project Title: Development and Commercialization of Ocular Diagnostic Tests Based on Vitreous Pr | ||||
Key People / Management
Lorraine Marchand -- Former CEO
Stephanie M Ecker -- Research & Development Project Manager
Bert Glaser -- CSO and Founder
Joshua Hines -- Director of Business Development
Matthew S Katz
Stephanie M Ecker -- Research & Development Project Manager
Bert Glaser -- CSO and Founder
Joshua Hines -- Director of Business Development
Matthew S Katz
